Actively Recruiting

Age: 18Years +
All Genders
NCT06966713

Predict Severe Traumatic Brain Injury

Led by University of Chicago · Updated on 2025-11-10

120

Participants Needed

2

Research Sites

184 weeks

Total Duration

On this page

Sponsors

U

University of Chicago

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

Severe traumatic brain injury (TBI) is associated with a 20-30% mortality rate and significant disability among most survivors. The Centers for Disease Control and Prevention (CDC) estimate that 2% of the U.S. population lives with disabilities directly attributable to TBI, with annual costs exceeding $76.5 billion. Current treatments are largely ineffective because they are instituted after irreversible damage has already occurred. By the time intracranial pressure (ICP) increases or brain tissue oxygen tension (PbtO2) decreases to harmful levels, it is often too late to reverse or repair the damage. A computerized method has been developed that can predict these injurious events ahead of time, allowing clinicians to intervene before further damage occurs. The goal of this proposal is to test these predictions in real time. The first phase of the project (Year 1) involves setting up the informatics infrastructure, with no patient interaction. In the second phase (Year 2), subjects, through surrogate decision-makers, will be enrolled in an observational study where data on intracranial pressure and brain tissue oxygen tension will be collected, and the prediction algorithm will be tested for accuracy. Clinical management will follow standard care protocols, and no additional interventions will be performed. Approximately 120 individuals will participate in this study at the University of Chicago and Ben Taub General Hospital in Houston. Data collected will include both the electronic medical record and data from bedside intensive care unit monitors. The electronic medical record includes demographic information, injury characteristics, laboratory values, and imaging data, while the intensive care unit monitor provides real-time vital signs such as intracranial pressure, brain tissue oxygen tension, and mean arterial pressure. These data will be securely stored in a research computer database. Efforts will be made to contact subjects or their caretakers at 6 months to follow up on recovery. This research aims to improve patient outcomes by providing predictions of further brain injury, with the potential for future interventions to prevent permanent brain damage.

CONDITIONS

Official Title

Predict Severe Traumatic Brain Injury

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients age >18 years old
  • Severe TBI with Glasgow Coma Scale score ≤8 after resuscitation without sedatives or paralytics
  • Clinical need for intracranial pressure and/or brain tissue oxygen monitoring per Brain Trauma Foundation guidelines
  • Ability to enroll during ICU stay
Not Eligible

You will not qualify if you...

  • Neurological exam indicating imminent brain death (fixed dilated pupils) or unreliable exam due to recent alcohol or seizure
  • Evidence of pregnancy
  • Contraindication to intracranial monitoring (e.g., uncorrected bleeding disorder, depressed skull fracture)
  • Unable to obtain informed consent from legal representative before research
  • Participation in another interventional clinical trial (except BOOST3 trial)
  • Prisoner

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Chicago

Chicago, Illinois, United States, 60637

Actively Recruiting

2

Baylor college of medicine

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

F

Farima Fakhri, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here